Our analysis highlights the concrete value, as prognostic value, of the MTRR and MTHFR gene variants in CRC patients and sheds additional light on potentially modifiable factors that could be targeted to improve prognosis in CRC survivors. Here, MTHFR is linked to colorectal carcinoma.